###begin article-title 0
Genetic background determines response to hemostasis and thrombosis
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 156 161 <span type="species:ncbi:10090">mouse</span>
Thrombosis is the fatal and disabling consequence of cardiovascular diseases, the leading cause of mortality and morbidity in Western countries. Two inbred mouse strains, C57BL/6J and A/J, have marked differences in susceptibility to obesity, atherosclerosis, and vessel remodeling. However, it is unclear how these diverse genetic backgrounds influence pathways known to regulate thrombosis and hemostasis. The objective of this study was to evaluate thrombosis and hemostasis in these two inbred strains and determine the phenotypic response of A/J chromosomes in the C57BL/6J background.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 17 21 <span type="species:ncbi:10090">mice</span>
A/J and C57Bl/6J mice were evaluated for differences in thrombosis and hemostasis. A thrombus was induced in the carotid artery by application of the exposed carotid to ferric chloride and blood flow measured until the vessel occluded. Bleeding and rebleeding times, as surrogate markers for thrombosis and hemostasis, were determined after clipping the tail and placing in warm saline. Twenty-one chromosome substitution strains, A/J chromosomes in a C57BL/6J background, were screened for response to the tail bleeding assay.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 389 392 389 392 <sup xmlns:xlink="http://www.w3.org/1999/xlink">A/J</sup>
###xml 402 405 402 405 <sup xmlns:xlink="http://www.w3.org/1999/xlink">A/J</sup>
###xml 419 422 419 422 <sup xmlns:xlink="http://www.w3.org/1999/xlink">A/J</sup>
###xml 652 656 652 656 <sup xmlns:xlink="http://www.w3.org/1999/xlink">A/J </sup>
###xml 668 671 668 671 <sup xmlns:xlink="http://www.w3.org/1999/xlink">A/J</sup>
###xml 58 62 <span type="species:ncbi:10090">mice</span>
###xml 84 88 <span type="species:ncbi:10090">mice</span>
###xml 195 199 <span type="species:ncbi:10090">mice</span>
###xml 221 225 <span type="species:ncbi:10090">mice</span>
###xml 337 341 <span type="species:ncbi:10090">mice</span>
###xml 499 503 <span type="species:ncbi:10090">mice</span>
###xml 505 509 <span type="species:ncbi:10090">Mice</span>
###xml 587 591 <span type="species:ncbi:10090">mice</span>
Thrombus occlusion time was markedly decreased in the A/J mice compared to C57BL/6J mice. Tail bleeding time was similar in the two strains, but rebleeding time was markedly increased in the A/J mice compared to C57BL/6J mice. Coagulation times and tail morphology were similar, but tail collagen content was higher in A/J than C57BL/6J mice. Three chromosome substitution strains, B6-Chr5A/J, B6-Chr11A/J, and B6-Chr17A/J, were identified with increased rebleeding time, a phenotype similar to A/J mice. Mice heterosomic for chromosomes 5 or 17 had rebleeding times similar to C57BL/6J mice, but when these two chromosome substitution strains, B6-Chr5A/J and B6-Chr17A/J, were crossed, the A/J phenotype was restored in these doubly heterosomic progeny.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 123 127 <span type="species:ncbi:10090">mice</span>
These results indicate that susceptibility to arterial thrombosis and haemostasis is remarkably different in C57BL/and A/J mice. Three A/J chromosome substitution strains were identified that expressed a phenotype similar to A/J for rebleeding, the C57Bl/6J background could modify the A/J phenotype, and the combination of two A/J QTL could restore the phenotype. The diverse genetic backgrounds and differences in response to vascular injury induced thrombosis and the tail bleeding assay, suggest the potential for identifying novel genetic determinants of thrombotic risk.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 16 17 16 17 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 580 581 580 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 582 583 582 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 862 863 862 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 864 865 864 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 197 202 <span type="species:ncbi:9606">human</span>
Family history [1] is the strongest risk factor for cardiovascular diseases (CVD). While a number of genetic mutations have been identified, these account for only a small percentage of the CVD in human populations. Thrombus formation on fissured atherosclerotic plaques is the precipitating event in the transition from a stable or subclinical atherosclerotic disease and leads to acute myocardial infarction, ischemic stroke or peripheral arterial occlusion. Arterial and venous thrombosis are complex responses and are influenced by multiple genetic and environmental factors [2-5]. Polymorphisms and mutations in coagulation factors, fibrinolytic factors, platelet surface receptors, methylenetetrahydrofalate reductase, endothelial nitric oxide synthase, and antioxidant enzymes have been implicated as genetic determinants of susceptibility to thrombosis [6,7]. Great strides have been made in the diagnosis and treatment of thrombosis in the last decade. However, strategies to prevent thrombosis have lagged far behind due, in part, to the contribution of multiple, and as yet undefined, genetic factors that lead to thrombotic risk. Moreover, it remains unclear how genetic background influences the function of molecules and pathways known to regulate thrombus formation and lysis and, thereby, contributes to the risk of thrombotic disease.
###end p 11
###begin p 12
###xml 162 163 162 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 232 233 232 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 330 331 330 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 486 488 486 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 29 34 <span type="species:ncbi:10090">mouse</span>
###xml 557 561 <span type="species:ncbi:10090">mice</span>
Many of the available inbred mouse strains, such as C57BL/6J (B6) and A/J, have been classified as resistant or susceptible to particular complex diseases (Table 1). These two strains have diverse responses to diet-induced obesity [8] (B6 susceptible; A/J resistant), diet-induced atherosclerosis (B6 susceptible; A/J resistant) [9], arterial ligation-induced neointimal hyperplasia (B6 resistant; A/J resistant), and ligation induced vessel remodeling (B6 resistant; A/J susceptible) [10]. These conditions are predisposing to thrombosis per se, but these mice have not been systematically evaluated for thrombosis. Clot formation and lysis, which ultimately determine thrombosis, requires platelet aggregation, coagulation, and fibrinolytic functions. Interactions among these pathways may occur and additional factors may modulate these processes. Identification of novel modulators and factors of these pathways can be identified by associating the phenotype with a location(s) on a specific chromosome, a quantitative trait locus (QTL).
###end p 12
###begin p 13
###xml 18 22 <span type="species:ncbi:10090">mice</span>
Identification of mice susceptible or resistant to obesity, atherosclerosis, and vascular injury
###end p 13
###begin p 14
###xml 78 80 78 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ob</sup>
###xml 104 108 <span type="species:ncbi:10090">mice</span>
R: resistant; S: susceptible. Reference provided by number in parenthesis. Lepob, Plg-/-, and PAI-F1-/- mice were in a B6 background.
###end p 14
###begin p 15
###xml 64 66 64 66 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 792 795 792 795 <sup xmlns:xlink="http://www.w3.org/1999/xlink">A/J</sup>
###xml 830 832 830 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 848 850 848 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 862 864 862 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 898 900 898 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 901 903 901 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 186 190 <span type="species:ncbi:10090">mice</span>
###xml 344 348 <span type="species:ncbi:10090">mice</span>
###xml 525 529 <span type="species:ncbi:10090">mice</span>
A panel of chromosome substitution strains (CSS) was generated [11] by a "marker-assisted" breeding program where the progeny of a B6 x A/J cross were successively backcrossed to the B6 mice. Genetic markers were used to identify homozygosity in the background (B6) and the individual A/J chromosome. These strains have one chromosome from A/J mice in a B6 background. This allows the identification of a trait in one or more CSS and implies that at least one QTL resides on this chromosome. Use of this panel requires fewer mice to determine the QTL than does a genome-wide scan. Another advantage is the ability for detection of QTL in the presence of other QTL. In addition, initial screens with the CSS simplify the fine-mapping of QTL. Several studies of this CSS panel, B6 Chr1-19, X, YA/J, have been reported for behavior [12], weight gain [13], sterols [13], and plasma amino acids levels [13,14], and have identified many more QTL than studies of the same traits using a genome-wide scan.
###end p 15
###begin p 16
###xml 68 72 <span type="species:ncbi:10090">mice</span>
###xml 290 294 <span type="species:ncbi:10090">mice</span>
The purpose of this study was to evaluate the two inbred strains of mice for prothrombotic risk, utilizing a ferric chloride vascular injury model, tail bleeding assay, and measures of coagulation and fibrinolysis. The results of this study indicate that the two inbred strains, B6 and A/J mice, have diverse prothrombotic phenotypes, unrelated to coagulation or platelet aggregation. In addition, in the CSS, expression of the A/J phenotypes, rebleeding time and arterial occlusion, was modified in the B6 background, and suggested that interactions occurred among the A/J QTL. Thus, it should be possible to identify independent genetic determinants of susceptibility to pathological haemostasis and thrombosis.
###end p 16
###begin title 17
Methods
###end title 17
###begin title 18
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 18
###begin p 19
###xml 37 40 37 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ob </sup>
###xml 158 160 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 317 319 317 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 676 678 676 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 131 135 <span type="species:ncbi:10090">mice</span>
###xml 162 166 <span type="species:ncbi:10090">mice</span>
###xml 272 276 <span type="species:ncbi:10090">mice</span>
###xml 380 384 <span type="species:ncbi:10090">mice</span>
###xml 459 463 <span type="species:ncbi:10090">mice</span>
###xml 476 480 <span type="species:ncbi:10090">mice</span>
###xml 707 711 <span type="species:ncbi:10090">mice</span>
###xml 763 767 <span type="species:ncbi:10090">mice</span>
###xml 863 867 <span type="species:ncbi:10090">Mice</span>
###xml 1012 1016 <span type="species:ncbi:10090">Mice</span>
The inbred strains, B6 (#000664), Lepob (#000632), A/J (#000646) and gene-targeted plasminogen (Plg) activator inhibitor deficient mice (PAI-1-/-) (#002507) [15] mice in a B6 background were obtained from Jackson Laboratory (Bar Harbor, Maine) at 6 wks-of-age. The Plg-/- mice were generated as previously described [16] and maintained in the B6 background, generated by crossing mice from the original mixed (B6:129) background for eight generations with B6 mice. The Plg-/- mice do not reproduce well and Plg heterozygous pairs were used for breeding. Genotypes (Plg+/+, Plg+/-, Plg-/-) of the offspring were determined by a PCR assay at 3-4 weeks-of-age from an ear punch [17]. Breeding pairs of the CSS mice were transferred from Dr. Nadeau's laboratory. All mice were housed and bred in the Biological Resource Unit at the Cleveland Clinic Foundation (CCF). Mice were housed in sterilized isolator cages, maintained on a 14 hr light/10 hr dark cycle, and were provided sterilized food and water ad libitum. Mice were fed a standard autoclavable laboratory diet consisting of: 23% protein, 4.5% fat, 6% fiber, (Purina, St. Louis, MO), and tested between 7 and 9 wks-of-age. All animal experiments were performed in accordance with a protocol approved by the Institutional Animal Care and Research Advisory Committee at CCF.
###end p 19
###begin title 20
Vascular injury
###end title 20
###begin p 21
###xml 77 78 77 78 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 104 106 104 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 107 109 107 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 469 471 469 471 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 599 601 599 601 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 125 129 <span type="species:ncbi:10090">Mice</span>
###xml 957 961 <span type="species:ncbi:10090">mice</span>
To induce thrombosis formation in the carotid artery, a ferric chloride (FeCl3) model of vessel injury [18,19] was employed. Mice were anesthetized with ketamine/xylazine (80 mg/kg, 5 mg/kg), a midline cervical incision was made and the left common carotid artery isolated by blunt dissection. The flow probe (Transonic Systems, model 0.5PSB) was placed under the artery and when a stable baseline was reached, a 0.5 x 2 mm strip of filter paper saturated with 10% FeCl3 solution was applied to the surface of the carotid artery for 3 min. Occlusion time was determined from the addition of the FeCl3 solution to the occlusion of the artery (minimum blood flow). The flow probe was in place from the establishment of the baseline until several min after the stable occlusion had been reached or stopped at 30 min if it had not occluded. Blood flow was recorded every 10 sec (Transonic Systems, model TS420). There was no difference in body weight among the mice that were tested in the vascular injury model.
###end p 21
###begin title 22
Bleeding and rebleeding assay
###end title 22
###begin p 23
###xml 29 33 <span type="species:ncbi:10090">mice</span>
For the tail bleeding assay, mice were anesthetized with ketamine/xylazine (80 mg/kg, 5 mg/kg), the tail prewarmed for 5 min in 10 mL of saline at 37degreesC in a water bath. The tail was lifted from the saline and a 5 mm tail segment amputated and immediately returned to the saline. Bleeding time was measured as the time between the start of bleeding to cessation of bleeding. With the tail remaining in the same saline solution, the rebleeding time was measured from the time between bleeding cessation and the start of the second bleeding.
###end p 23
###begin title 24
###xml 23 24 19 20 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
Coagulation, Plg, alpha2-antiplasmin, fibrinogen, fibrinolytic and PAI-1 assays
###end title 24
###begin p 25
###xml 414 420 414 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 421 423 421 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 479 481 479 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 674 676 674 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 742 744 742 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 871 872 867 868 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 489 494 <span type="species:ncbi:9940">sheep</span>
###xml 500 505 <span type="species:ncbi:10090">mouse</span>
###xml 563 568 <span type="species:ncbi:10090">mouse</span>
###xml 825 829 <span type="species:ncbi:10090">mice</span>
###xml 860 865 <span type="species:ncbi:10090">mouse</span>
###xml 950 955 <span type="species:ncbi:10090">mouse</span>
###xml 1072 1077 <span type="species:ncbi:10090">mouse</span>
Mice were anesthetized with Isoflurane (Abbott), bled from the orbital sinus into uncoated capillary tubes, and a drop of blood immediately placed on a reagent strip (Synbiotics) for prothrombin time (PT) or activated partial thromboplastin time (aPTT) determinations and inserted into the precalibrated Coagulation Analyzer (SCA2000, Synbiotics). PAI-1 activity was determined according to the method of Chandler et al [20]. PAI-1 antigen concentration was determined by ELISA [21] using sheep-anti mouse PAI-1 (American Diagnostica) as the capture antibody and mouse PAI-1 (American Diagnostica) as the standard (0-3.5 ng/mL). Plg was determined with a chromogenic assay [22] and the fibrinolytic activity determined by fibrin degradation [23]. For the negative controls in these assays, plasma from PAI-1 or Plg deficient mice was used. Functionally active mouse alpha2-antiplasmin was determined with a plasmin capture assay and detection with a mouse antibody (Molecular Innovations, Southfield, MI), and fibrinogen with an ELISA assay with antibodies that recognize mouse fibrinogen (Hyphen BioMed, France).
###end p 25
###begin title 26
Histochemical and immunohistochemistry analysis
###end title 26
###begin p 27
###xml 475 480 <span type="species:ncbi:10090">mouse</span>
The frozen tails or injured carotids in OCT were sectioned at 5 mum thickness and stained with Masson's Trichrome (HT 15, Sigma Diagnostics). For quantitative analysis of collagen area in the tail sections, four sections from 2-3 sites were measured using computer assisted image analysis (Image-Pro Plus, Cybernetics). For the area determination of the injured carotid lumen, 3-4 sections from different sites approximately 100 mum apart were analyzed and averaged for each mouse.
###end p 27
###begin title 28
Statistics
###end title 28
###begin p 29
###xml 215 217 213 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ob</sup>
###xml 309 311 307 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 482 483 480 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 592 594 590 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 96 100 <span type="species:ncbi:10090">mice</span>
###xml 228 232 <span type="species:ncbi:10090">mice</span>
###xml 398 402 <span type="species:ncbi:10090">mice</span>
Data are presented as mean +/- SEM. The statistical analysis for comparisons between A/J and B6 mice and between wild-type (WT) and Plg-/- littermates was compared with a two-tailed t-test. Differences among B6, Lepob, PAI-1-/- mice were determined by a one-way ANOVA and a Newman-Keuls post-test. A value of P < 0.05 was considered significant. The statistical analysis for comparisons between B6 mice and CSS were determined with two-tail t-tests and the level of the significant P-values (see figure legends) determined with a Bonferroni correction to account for multihypothesis testing [13].
###end p 29
###begin title 30
Results
###end title 30
###begin title 31
###xml 64 68 <span type="species:ncbi:10090">mice</span>
Marked differences in arterial thrombus formation in B6 and A/J mice
###end title 31
###begin p 32
###xml 8 10 8 10 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 39 41 39 41 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 292 294 292 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 387 389 387 389 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 720 722 712 714 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 819 821 811 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 895 897 887 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 1040 1042 1032 1034 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 1127 1128 1119 1120 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 1398 1400 1382 1384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 151 156 <span type="species:ncbi:10090">mouse</span>
###xml 279 283 <span type="species:ncbi:10090">mice</span>
###xml 327 331 <span type="species:ncbi:10090">mice</span>
###xml 364 368 <span type="species:ncbi:10090">mice</span>
###xml 418 422 <span type="species:ncbi:10090">mice</span>
###xml 479 483 <span type="species:ncbi:10090">mice</span>
###xml 806 810 <span type="species:ncbi:10090">mice</span>
###xml 840 844 <span type="species:ncbi:10090">mice</span>
###xml 1202 1206 <span type="species:ncbi:10090">mice</span>
###xml 1219 1223 <span type="species:ncbi:10090">mice</span>
###xml 1345 1349 <span type="species:ncbi:10090">mice</span>
###xml 1427 1431 <span type="species:ncbi:10090">mice</span>
###xml 1452 1456 <span type="species:ncbi:10090">mice</span>
The FeCl3 cartoid artery injury model [24], a well-characterized arterial thrombosis model, was used to induce an occlusive thrombus in the B6 and A/J mouse strains under investigation. A marked difference in arterial thrombus occlusion time was found between the B6 and the A/J mice (Figure 1A). The occlusion time in the A/J mice was 2-fold less than for the B6 mice. A 5% dose of FeCl3 was tested in the A/J and B6 mice and the occlusion time was lower in the A/J than the B6 mice, the same results as with the 10% dose. The occlusion time (min for both B6 (15 +/- 3, n = 3) and A/J (8 +/- 1, n = 3) at 5% were longer than at 10% for B6 (10 +/- 1, n = 17 and A/J (5 +/- 2, n = 14). The curves of blood flow after FeCl3 application indicated a pattern with a gradual decrease before occlusion for the B6 mice (Figure 1B), but for the A/J mice the blood flow decreased abruptly to zero (Figure 1C), demonstrating a marked difference from the B6 strain. The mean occlusion times were significantly different between the two strains (Figure 1A). The size of the carotids in the two strains was noticeably different. The area (mm2) of the lumen (0.066 +/- 0.007, n = 6) was significantly less in the A/J mice than for B6 mice (0.128 +/- 0.007, n = 6). However, the ratio of the thrombus to lumen was similar for A/J (0.63 +/- 0.03) compared to B6 mice (0.67 +/- 0.09). Calculated sheer stress rates [25] were 14% less in the A/J mice when compared to B6 mice.
###end p 32
###begin p 33
###xml 0 42 0 42 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Arterial occlusion time in B6 and A/J mice</bold>
###xml 44 59 44 59 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Panels A and B </bold>
###xml 191 200 191 200 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Panel A: </bold>
###xml 209 218 209 218 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Panel B: </bold>
###xml 228 237 228 237 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Panel C: </bold>
###xml 348 350 346 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 38 42 <span type="species:ncbi:10090">mice</span>
###xml 203 207 <span type="species:ncbi:10090">mice</span>
###xml 222 226 <span type="species:ncbi:10090">mice</span>
###xml 284 288 <span type="species:ncbi:10090">mice</span>
###xml 369 373 <span type="species:ncbi:10090">mice</span>
Arterial occlusion time in B6 and A/J mice. Panels A and B are representative occlusion curves from each genotype. Red arrows indicate duration of ferric chloride application to the carotid. Panel A: B6 mice, Panel B: A/J mice. Panel C: Arterial occlusion time, mean +/- SEM of 14-17 mice per genotype. Symbol indicates a significant difference (**P < 0.01) between B6 mice determined with a t-test.
###end p 33
###begin title 34
###xml 52 56 <span type="species:ncbi:10090">mice</span>
Marked differences in rebleeding time in B6 and A/J mice
###end title 34
###begin p 35
###xml 389 391 389 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 523 526 523 526 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ob </sup>
###xml 596 599 596 599 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ob </sup>
###xml 640 642 640 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 711 714 711 714 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ob </sup>
###xml 727 729 727 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 1016 1019 1016 1019 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ob </sup>
###xml 273 278 <span type="species:ncbi:10090">mouse</span>
###xml 356 360 <span type="species:ncbi:10090">mice</span>
###xml 376 380 <span type="species:ncbi:10090">mice</span>
###xml 477 481 <span type="species:ncbi:10090">mice</span>
###xml 526 530 <span type="species:ncbi:10090">mice</span>
###xml 565 569 <span type="species:ncbi:10090">mice</span>
###xml 599 603 <span type="species:ncbi:10090">mice</span>
###xml 714 718 <span type="species:ncbi:10090">mice</span>
###xml 799 803 <span type="species:ncbi:10090">mice</span>
###xml 886 890 <span type="species:ncbi:10090">mice</span>
###xml 906 910 <span type="species:ncbi:10090">mice</span>
###xml 968 972 <span type="species:ncbi:10090">mice</span>
###xml 988 992 <span type="species:ncbi:10090">mice</span>
###xml 1019 1023 <span type="species:ncbi:10090">mice</span>
###xml 1150 1154 <span type="species:ncbi:10090">mice</span>
The bleeding time, an indicator of hemostatic activity, was determined after prewarming the tail, clipping a 5 mm segment, placing the tail in warm saline and measuring the time for the bleeding to stop. We found this procedure was consistent and reproducible in different mouse strains and was not gender dependent. Bleeding time was not different in A/J mice compared to B6 mice (Figure 2A). In order to determine if specific pathways were altered in the B6 and A/J strains, mice with known alterations in hemostasis, Lepob mice, or thrombosis, Plg-/- and PAI-/- mice, were also tested. The Lepob mice have impaired platelet aggregation [26] and were evaluated as a reference for platelet function. In the Lepob mice (Figure 2A) there was nearly a 10-fold increase in bleeding time compared to B6 mice. Bleeding time was also significantly (P = 0.0001) increased by 66% in the Plg-/- mice compared to WT mice littermates. Bleeding time was not different in PAI-1-/- mice compared to B6 mice. In contrast to the Lepob mice with a platelet defect and 10-fold increase in bleeding time, there was no difference in the bleeding time between B6 and A/J mice and suggested platelet aggregation is not altered in these two strains.
###end p 35
###begin p 36
###xml 0 44 0 44 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Bleeding and rebleeding time in B6, A/J, Lep</bold>
###xml 44 46 44 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ob</sup>
###xml 46 72 46 72 <bold xmlns:xlink="http://www.w3.org/1999/xlink">, Plg-/- and PAI-1-/- mice</bold>
###xml 74 86 74 86 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Panel A, B: </bold>
###xml 114 126 114 126 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Panel C, D: </bold>
###xml 314 317 314 317 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ob </sup>
###xml 424 426 424 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 436 438 436 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 449 451 449 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 68 72 <span type="species:ncbi:10090">mice</span>
###xml 477 481 <span type="species:ncbi:10090">mice</span>
###xml 520 524 <span type="species:ncbi:10090">mice</span>
Bleeding and rebleeding time in B6, A/J, Lepob, Plg-/- and PAI-1-/- mice. Panel A, B: Bleeding time (seconds) and Panel C, D: Rebleeding time (seconds). To determine statistical differences, values from B6 and A/J and from WT and Plg-/- littermates were compared with a t-test, and values from B6, PAI-1-/- and Lepob were compared by a one-way ANOVA and a Newman-Keuls post-test. Symbols indicate a significant difference (*P < 0.05, **P < 0.01, ***P < 0.001) between B6 or WT mice. Values are the mean +/- SEM of 10-34 mice per genotype.
###end p 36
###begin p 37
###xml 157 159 157 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 223 225 223 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 325 328 325 328 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ob </sup>
###xml 485 487 485 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 606 608 606 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 234 238 <span type="species:ncbi:10090">mice</span>
###xml 251 255 <span type="species:ncbi:10090">mice</span>
###xml 328 332 <span type="species:ncbi:10090">mice</span>
###xml 345 349 <span type="species:ncbi:10090">mice</span>
###xml 455 459 <span type="species:ncbi:10090">mice</span>
###xml 534 538 <span type="species:ncbi:10090">mice</span>
###xml 580 584 <span type="species:ncbi:10090">mice</span>
###xml 682 686 <span type="species:ncbi:10090">mice</span>
Rebleeding time, an indicator of thrombus stability, was measured as the time between the cessation of bleeding and the start of the second bleeding (Figure 2B). Rebleeding times were significantly higher in A/J (2.6-fold, P < 0.001) mice than the B6 mice. In contrast, the rebleeding time was nearly 8.5-fold less in the Lepob mice than the B6 mice. To determine how alterations in the fibrinolytic system may affect rebleeding time, Plg-/- and PAI-1-/- mice were also tested (Figure 2B). Rebleeding time was not different in Plg-/- mice compared to WT littermates, but PAI-1-/- mice had a significantly (P < 0.05) reduced rebleeding time, which was 1.8-fold lower than for the B6 mice. Although a Plg deficiency did not result in a prolonged rebleeding time as anticipated, a PAI-1 deficiency resulted in a shortened time. The markedly increased rebleeding time in the A/J may suggest differences in the regulation of the Plg network.
###end p 37
###begin title 38
###xml 54 58 <span type="species:ncbi:10090">mice</span>
No difference in blood coagulation between B6 and A/J mice
###end title 38
###begin p 39
###xml 653 654 653 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 581 585 <span type="species:ncbi:10090">mice</span>
###xml 632 637 <span type="species:ncbi:10090">mouse</span>
To determine if differences in coagulation were contributing factors to the bleeding and rebleeding results, prothrombin time (PT) and activated partial thromboplastin time (aPTT) were measured. PT is a measurement of the extrinsic coagulation pathway (activation of Factor VII by tissue factor) while aPTT is a measurement of the intrinsic pathway (activation of Factors XII, XI, IX and VIII). The products of both pathways activate Factor X, which initiates the common pathway leading to thrombin generation and fibrin clot formation. PT and aPTT were measured in the B6 and A/J mice and values were not different between the two mouse strains (Table 2). These results suggest that the coagulation pathway is not different in the two inbred strains.
###end p 39
###begin p 40
###xml 67 72 <span type="species:ncbi:10090">mouse</span>
Coagulation and Plasminogen System Parameters in B6 and A/J inbred mouse strains
###end p 40
###begin p 41
###xml 30 32 28 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 42 44 40 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
Values are the mean +/- SEM. *P < 0.05, **P < 0.01. n = 5-8.
###end p 41
###begin title 42
###xml 36 40 <span type="species:ncbi:10090">mice</span>
Plg and PAI-1 higher in A/J than B6 mice
###end title 42
###begin p 43
###xml 127 128 123 124 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 213 214 209 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 950 952 946 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 44 48 <span type="species:ncbi:10090">mice</span>
###xml 60 64 <span type="species:ncbi:10090">mice</span>
###xml 172 176 <span type="species:ncbi:10090">mice</span>
###xml 201 205 <span type="species:ncbi:10090">mice</span>
###xml 324 328 <span type="species:ncbi:10090">mice</span>
###xml 408 412 <span type="species:ncbi:10090">mice</span>
###xml 445 449 <span type="species:ncbi:10090">mice</span>
###xml 763 767 <span type="species:ncbi:10090">mice</span>
###xml 848 852 <span type="species:ncbi:10090">mice</span>
###xml 869 873 <span type="species:ncbi:10090">mice</span>
###xml 1009 1013 <span type="species:ncbi:10090">mice</span>
###xml 1049 1053 <span type="species:ncbi:10090">mice</span>
###xml 1214 1219 <span type="species:ncbi:10090">mouse</span>
Plg concentration was 34% higher in the A/J mice than in B6 mice. In addition, fibrinolytic activity, PAI-1 activity, and alpha2-anitplasmin were also increased in the A/J mice when compared to the B6 mice (Table 2). The functional consequences of these differences are not clear, since fibrinogen is also higher in the A/J mice. To determine whether there were protein structure changes of Plg from the A/J mice, plasma from the B6 and the A/J mice were subjected to electrophoresis under reduced, non-reduced, and non-denaturing conditions. No difference in migration for immunostained Plg under these conditions was observed (data not shown). The density of the Western blot from SDS-PAGE under reducing conditions of plasma of varying volumes from B6 and A/J mice was compared and the density of the bands was 56% higher in the A/J than the B6 mice (six individual mice were tested on at least two occasions) from the same amount of plasma (Fig. 1B). Thus, the concentration of Plg in plasma from the A/J mice was higher than plasma from the B6 mice as determined by two methods and no difference in migration after electrophoresis was observed, suggesting no marked changes in the structure of Plg in the two mouse strains.
###end p 43
###begin title 44
Tail morphology in B6 and A/J
###end title 44
###begin p 45
###xml 281 282 281 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 424 426 424 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 513 515 513 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 671 673 671 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
###xml 17 21 <span type="species:ncbi:10090">mice</span>
###xml 170 174 <span type="species:ncbi:10090">mice</span>
###xml 708 713 <span type="species:ncbi:10090">mouse</span>
###xml 773 777 <span type="species:ncbi:10090">mice</span>
###xml 839 843 <span type="species:ncbi:10090">mice</span>
###xml 881 885 <span type="species:ncbi:10090">mice</span>
The tails of the mice were examined for differences that might account for the variations in the bleeding and rebleeding values. Sections of the tail from the B6 and A/J mice were stained with Hematoxylin/Eosin or Masson's Trichrome and representative sections are shown in Figure 3. No obvious qualitative differences were observed in hair follicles, sebaceous glands, or center bone/cartilage in Hematoxylin/Eosin (Figure 3A) stained sections. Sections of the tails were stained with Masson's Trichrome (Figure 3B) that detects collagen, the major platelet adhesive substratum for initiation of thrombus formation. Collagen content (% tail area) was quantified (Figure 3C) from 3-4 sections from 2-3 areas/mouse. The amount of collagen was greater in the A/J than the B6 mice (P < 0.05). Collagen in vessels in adipose tissue in the A/J mice is also increased compared to the B6 mice (data not shown).
###end p 45
###begin p 46
###xml 0 28 0 28 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Tail morphology and collagen</bold>
###xml 136 145 136 145 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Panel A: </bold>
###xml 226 235 226 235 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Panel B: </bold>
###xml 353 362 353 362 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Panel C: </bold>
###xml 656 658 654 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 220 224 <span type="species:ncbi:10090">mice</span>
###xml 307 311 <span type="species:ncbi:10090">mice</span>
###xml 551 556 <span type="species:ncbi:10090">mouse</span>
###xml 593 597 <span type="species:ncbi:10090">mice</span>
###xml 677 681 <span type="species:ncbi:10090">mice</span>
Tail morphology and collagen. Tails were excised, embedded in OCT, sectioned, and stained with Hematoxylin/Eosin or Masson's Trichrome. Panel A: Representative sections stained with hematoxylin and eosin from B6 and A/J mice. Panel B: Representative sections stained with Masson's Trichrome from B6 and A/J mice. The blue color identifies the collagen. Panel C: The percentage of the collagen area (excluding center bone/cartilage) of the total tail area of each section was determined in 3-4 sections at 2-3 sites for each tail and averaged for each mouse. Values are the mean +/- SEM of 4-8 mice per genotype. Symbol indicates a significant difference (*P < 0.05) between B6 mice determined by t-test.
###end p 46
###begin title 47
Tail bleeding assay identifies three chromosomes with QTL for rebleeding in CSS
###end title 47
###begin p 48
###xml 144 146 144 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 249 252 249 252 <sup xmlns:xlink="http://www.w3.org/1999/xlink">A/J</sup>
###xml 265 267 265 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 384 386 384 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 566 570 566 570 <sup xmlns:xlink="http://www.w3.org/1999/xlink">A/J </sup>
###xml 591 595 591 595 <sup xmlns:xlink="http://www.w3.org/1999/xlink">A/J </sup>
###xml 624 626 624 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 753 757 753 757 <sup xmlns:xlink="http://www.w3.org/1999/xlink">A/J </sup>
###xml 793 795 793 795 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 171 175 <span type="species:ncbi:10090">mice</span>
###xml 340 344 <span type="species:ncbi:10090">mice</span>
###xml 512 516 <span type="species:ncbi:10090">mice</span>
###xml 536 540 <span type="species:ncbi:10090">mice</span>
###xml 678 682 <span type="species:ncbi:10090">mice</span>
###xml 724 728 <span type="species:ncbi:10090">mice</span>
###xml 870 874 <span type="species:ncbi:10090">mice</span>
###xml 985 989 <span type="species:ncbi:10090">mice</span>
###xml 1047 1051 <span type="species:ncbi:10090">mice</span>
Using the tail bleeding/rebleeding assay as a surrogate marker for hemostasis and thrombosis, the CSS were screened. The bleeding times (Figure 4A) for the B6 and the A/J mice were not different, but 6six of the strains, B6-Chr5, 6, 8, 14, 15, and YA/J, had lower (P < 0.002) bleeding times (49-79 seconds) compared to the value for the B6 mice (121 sec). The rebleeding time (Figure 4B), determined as the time between bleeding cessation and initiation of the second bleeding, was markedly increased in the A/J mice compared to the B6 mice and two strains, B6-Chr11A/J (CSS-11) and B6-Chr17A/J (CSS-17), had significantly (P < 0.002) longer rebleeding times compared to the B6 mice that were similar to values from the A/J mice. Another strain, B6-Chr5A/J (CSS-5), approached significance at P < 0.008. The rebleeding time was stopped at 600 sec, and the percentage of mice with this value determined for the three strains: CSS-5-60%, CSS-11-60% and CSS-A17-46%. The percentage of B6 mice with a rebleeding time of 600 sec was 7% and for the A/J mice the percentage was 85%.
###end p 48
###begin p 49
###xml 0 39 0 39 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Bleeding and rebleeding time in the CSS</bold>
###xml 41 50 41 50 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Panel A: </bold>
###xml 75 84 75 84 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Panel B: </bold>
###xml 300 302 298 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 374 376 372 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 145 149 <span type="species:ncbi:10090">mice</span>
###xml 186 190 <span type="species:ncbi:10090">mice</span>
Bleeding and rebleeding time in the CSS. Panel A: Bleeding Time (seconds). Panel B: Rebleeding Time (seconds). Bars are the mean +/- SEM of 7-28 mice. Statistical differences between B6 mice and CSS were determined with a t-test, and a Bonferroni correction was made to determine significance value (P < 0.002). Symbols indicate a significant difference between B6 values. *P < 0.002.
###end p 49
###begin p 50
###xml 223 224 223 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 427 431 427 431 <sup xmlns:xlink="http://www.w3.org/1999/xlink">A/J </sup>
###xml 441 445 441 445 <sup xmlns:xlink="http://www.w3.org/1999/xlink">A/J </sup>
###xml 90 94 <span type="species:ncbi:10090">mice</span>
###xml 121 125 <span type="species:ncbi:10090">mice</span>
###xml 149 153 <span type="species:ncbi:10090">mice</span>
###xml 274 278 <span type="species:ncbi:10090">mice</span>
###xml 322 326 <span type="species:ncbi:10090">mice</span>
Rebleeding time in the parent strains and CSS were compared to values from the progeny of mice that were crossed with B6 mice to produce heterosomic mice for the CSS-5, (B6xCSS-5)F1 and CSS-17 (B6xCSS-17)F1 strains (Figure 5). The rebleeding values for CSS-5F1 and CSS-17F1 mice were similar to the B6 rather than the A/J mice, suggesting the A/J trait is recessive. Bleeding and rebleeding in the progeny of the cross, B6-Chr5A/J x B6-Chr17A/J (CSS-5 x CSS-17) resulted in the recovery of the A/J phenotype in the progeny of these double heterosomic strains. Thus, despite the heterosomic chromosomes of 5 and 17 in the progeny of the CSS-5 x CSS-17, the phenotype was now similar to A/J. This suggested that traits on the A/J chromosomes were interacting to produce the phenotype.
###end p 50
###begin p 51
###xml 0 51 0 51 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Bleeding and rebleeding time in the CSS backcrosses</bold>
###xml 53 62 53 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Panel A: </bold>
###xml 90 99 90 99 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Panel B: </bold>
###xml 458 460 456 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 531 533 529 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 152 156 <span type="species:ncbi:10090">mice</span>
###xml 225 229 <span type="species:ncbi:10090">mice</span>
###xml 299 303 <span type="species:ncbi:10090">mice</span>
###xml 340 344 <span type="species:ncbi:10090">mice</span>
Bleeding and rebleeding time in the CSS backcrosses. Panel A: Bleeding Time (seconds) and Panel B: Rebleeding Time (seconds) were tested in heterosomic mice, (B6xCSS-5)F1 (5F1) and (B6xCSS-17)F1 (17F1) and doubly heterosomic mice for chromosomes 5 and 17 (5 x 17). Bars are the mean +/- SEM of 5-28 mice. Statistical differences between B6 mice and the CSS were determined with a t-test, and a Bonferroni correction was made to determine significance value (P < 0.01). Symbols indicate a significant difference between B6 values. *P < 0.01.
###end p 51
###begin title 52
Interactions of CSS for PAI-1 antigen and activity
###end title 52
###begin p 53
###xml 79 80 75 76 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 134 135 130 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 205 206 197 198 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 332 334 324 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 589 590 575 576 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 622 624 608 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 698 700 681 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 145 149 <span type="species:ncbi:10090">mice</span>
###xml 270 274 <span type="species:ncbi:10090">mice</span>
###xml 286 290 <span type="species:ncbi:10090">mice</span>
###xml 397 401 <span type="species:ncbi:10090">mice</span>
###xml 482 486 <span type="species:ncbi:10090">mice</span>
###xml 578 582 <span type="species:ncbi:10090">mice</span>
###xml 651 655 <span type="species:ncbi:10090">mice</span>
###xml 791 795 <span type="species:ncbi:10090">mice</span>
###xml 815 819 <span type="species:ncbi:10090">mice</span>
Components of the Plg system reside on chromosomes CSS-5 (PAI-1), CSS-11 (alpha2-antiplasmin), and CSS-17 (Plg). As reported in Table 2, the A/J mice had increased Plg antigen, fibrinolytic activity, alpha2-antiplasmin, PAI-1 activity and fibrinogen when compared to B6 mice. In CSS-17 mice, the Plg antigen was also significantly (P = 0.015) increased (152 +/- 6, n = 12) when compared to the B6 mice, but for CSS-5 and CSS-5 x 17, the Plg antigen was similar to values for the B6 mice. Fibrinolytic activity was not different in the CSS-5 or CSS-17 strains compared to the B6 mice. alpha2-antiplasmin was significantly (P = < 0.01) reduced in CSS-5 mice (142 +/- 4 mug/mL, n = 5), significantly (P < 0.05) higher in the CSS-11 (201 +/- 6, n = 8), but not different in CSS-17 or CSS-5 x 17 mice compared to the B6 mice.
###end p 53
###begin p 54
###xml 121 122 121 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 289 293 <span type="species:ncbi:10090">mice</span>
###xml 604 608 <span type="species:ncbi:10090">mice</span>
###xml 835 839 <span type="species:ncbi:10090">mice</span>
###xml 870 874 <span type="species:ncbi:10090">mice</span>
PAI-1 antigen and activity were determined in the CSS with increased rebleeding times, CSS-5, CSS-11, and CSS-17 (Figure 6), the heterosomic, CSS-5F1, CSS-17F1, and double hetersomic, CSS-5 x 17. CSS-5, CSS-17, CSS-5F1, and CSS-17F1 generally had reduced PAI-1 antigen when compared to B6 mice. The reduced PAI-1 antigen was a dominant trait due to the fact that the values were similar in the homosomic and heterosomic CSS-5 and CSS-17. The CSS-5 x CSS-17 double heterosomic strains had values similar to the B6 and A/J parent strains. PAI-1 activity was significantly reduced in the CSS-5 and CSS-17F1 mice, but again in the CSS-5 x CSS-17 strain the value for PAI-1 activity was restored to the value of the B6 and A/J parent strains. The PAI-1 antigen (5.4 ng/mL +/- 0.5, n = 7) and activity (170 U/mL +/- 20, n = 6) in the CSS-11 mice was not different than for B6 mice.
###end p 54
###begin p 55
###xml 0 28 0 28 <bold xmlns:xlink="http://www.w3.org/1999/xlink">PAI-1 in the CSS backcrosses</bold>
###xml 30 39 30 39 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Panel A: </bold>
###xml 72 81 72 81 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Panel B: </bold>
###xml 439 441 437 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 512 514 510 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 137 141 <span type="species:ncbi:10090">mice</span>
###xml 210 214 <span type="species:ncbi:10090">mice</span>
###xml 284 288 <span type="species:ncbi:10090">mice</span>
###xml 325 329 <span type="species:ncbi:10090">mice</span>
PAI-1 in the CSS backcrosses. Panel A: Plasma PAI-1 antigen (ng/mL) and Panel B: Plasma PAI-1 activity (U/mL) were tested in heterosomic mice, (B6xCSS-5)F1 (5F1) and (B6xCSS-17)F1 (17F1) and doubly heterosomic mice for chromosomes 5 and 17 (5 x 17). Bars are the mean +/- SEM of 5-18 mice. Statistical differences between B6 mice and CSS were determined with a t-test, and a Bonferroni correction was made to determine significance value (P < 0.01). Symbols indicate a significant difference between B6 values. *P < 0.01.
###end p 55
###begin title 56
Interactions of CSS for arterial thrombus formation
###end title 56
###begin p 57
###xml 176 178 176 178 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 193 194 193 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 256 260 <span type="species:ncbi:10090">mice</span>
###xml 358 362 <span type="species:ncbi:10090">mice</span>
###xml 460 464 <span type="species:ncbi:10090">mice</span>
###xml 484 488 <span type="species:ncbi:10090">mice</span>
###xml 534 538 <span type="species:ncbi:10090">mice</span>
###xml 599 603 <span type="species:ncbi:10090">mice</span>
The tail bleeding assay was rapid and facilitated the screening of the 21 CSS strains, and subsequently the identified strains were tested for arterial occlusion after the FeCl3 injury (Figure 7). The CSS-5 and CSS-17 had occlusion times similar to the B6 mice, but the doubly heterosomic CSS-5 x CSS-17 progeny had occlusion times higher than either the B6 mice or the heterosomic CSS-5F1 and CSS-17F1 or the A/J strains. In double heterosomic CSS-5 x CSS-17 mice, only one or three mice tested had occluded by 30 min; the other two mice did not occlude by 30 min. While only a small number of CSS mice have been tested for the arterial occlusion, the results suggest that interaction of the genes on chromosome 5 and 17 also determines arterial occlusion time.
###end p 57
###begin p 58
###xml 0 46 0 46 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Arterial occlusion time in the CSS backcrosses</bold>
###xml 396 398 394 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 469 471 467 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 93 97 <span type="species:ncbi:10090">mice</span>
###xml 167 171 <span type="species:ncbi:10090">mice</span>
###xml 241 245 <span type="species:ncbi:10090">mice</span>
###xml 282 286 <span type="species:ncbi:10090">mice</span>
Arterial occlusion time in the CSS backcrosses. Occlusion time was determined in heterosomic mice, (B6xCSS-5)F1 (5F1) and (B6xCSS-17)F1 (17F1), and doubly heterosomic mice for chromosomes 5 and 17 (5 x 17). Bars are the mean +/- SEM of 5-18 mice. Statistical differences between B6 mice and CSS were determined with a t-test, and a Bonferroni correction was made to determine significance value (P < 0.02). Symbols indicate a significant difference between B6 values. *P < 0.0001.
###end p 58
###begin title 59
Discussion
###end title 59
###begin p 60
###xml 84 88 <span type="species:ncbi:10090">mice</span>
###xml 461 465 <span type="species:ncbi:10090">mice</span>
###xml 553 557 <span type="species:ncbi:10090">mice</span>
###xml 925 929 <span type="species:ncbi:10090">Mice</span>
###xml 1179 1183 <span type="species:ncbi:10090">mice</span>
In this study, thrombotic risk was systematically assessed in two inbred strains of mice that have marked differences in susceptibility to diet-induced obesity, diet-induced atherosclerosis, and ligation-induced neointimal hyperplasia and vessel remodeling. Arterial occlusion time, tail bleeding and rebleeding time were evaluated as potential predictors of thrombotic response. Assessments of the two inbred strains were compared to values from gene targeted mice of the Plg network with altered fibrinolytic responses, as well as in leptin deficient mice with a reduced platelet function. Marked differences were found in the thrombotic response among the two inbred strains, B6 and A/J, and the observed differences were not correlated with change in coagulation or platelet function. Screening the CSS identified three chromosomes that harbored genes which contributed to the A/J phenotype of increased rebleeding time. Mice homosomic for these chromosomes or doubly heterosomic for two of the chromosomes, 5 and 17, were required to express the A/J phenotype, elevated rebleeding time. PAI-1 antigen and activity were decreased in both CSS-5 and CSS-17 and the heterosomic mice, CSS-5F1 and CSS-17F1, but not in the CSS-11 strain. Values were restored in the doubly heterosomic for two of chromosomes, 5 and 17. Arterial occlusion time was similar to B6 in the CSS-5 and CSS-17 homozygous strains, but increased in doubly heterosomic for two of chromosomes, 5 and 17.
###end p 60
###begin p 61
###xml 8 9 8 9 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 140 142 140 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 249 251 249 251 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 269 271 269 271 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 446 448 446 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 1001 1004 1001 1004 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ob </sup>
###xml 1010 1012 1010 1012 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1150 1152 1150 1152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 61 65 <span type="species:ncbi:10090">mice</span>
###xml 351 355 <span type="species:ncbi:10090">mice</span>
###xml 375 379 <span type="species:ncbi:10090">mice</span>
###xml 469 473 <span type="species:ncbi:10116">rats</span>
###xml 797 801 <span type="species:ncbi:10090">mice</span>
###xml 902 906 <span type="species:ncbi:10090">mice</span>
###xml 1004 1008 <span type="species:ncbi:10090">mice</span>
###xml 1107 1111 <span type="species:ncbi:10090">mice</span>
###xml 1205 1209 <span type="species:ncbi:10090">mice</span>
###xml 1239 1243 <span type="species:ncbi:10090">mice</span>
The FeCl3-induced model of vascular injury and thrombosis in mice is now widely used to evaluate genetic and pharmacological interventions [24]. The two inbred strains had marked differences in the time for occlusion of the carotid artery after FeCl3 injury. After FeCl3 treatment, thrombus formation and occlusion was remarkably shortened in the A/J mice compared to the B6 mice. These results have not previously been reported. A recent study [25] of sheer stress in rats, found that the magnitude of changes in sheer stress with increased blood flow varied with the different strains. Further investigation, beyond the scope of this study would be necessary to determine the contribution in the differences in size and sheer stress of the carotids to arterial occlusion rates in the B6 and A/J mice. In preliminary studies, we have noted differences in the composition of the thrombus in B6 and A/J mice. The pattern of blood flow cessation for the two inbred strains was different than for the Lepob mice [26] with impaired platelet function, and coagulation time was similar in the two strains. In the mice with deficiencies of the Plg network [27], thrombus formation time was reduced in the Plg-/- mice, but increased in the PAI-/- mice, suggesting that alterations in plasmin activity that affect the rate of clot lysis, can modulate the events leading to occlusive thrombus formation.
###end p 61
###begin p 62
###xml 168 174 168 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 175 177 175 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 315 321 315 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 322 324 322 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 779 781 779 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 820 822 820 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 53 57 <span type="species:ncbi:10090">mice</span>
###xml 155 159 <span type="species:ncbi:10090">mice</span>
###xml 202 206 <span type="species:ncbi:10090">mice</span>
###xml 233 237 <span type="species:ncbi:10090">mice</span>
###xml 336 340 <span type="species:ncbi:10090">mice</span>
###xml 525 529 <span type="species:ncbi:10090">mice</span>
###xml 679 683 <span type="species:ncbi:10090">Mice</span>
###xml 1017 1021 <span type="species:ncbi:10090">mice</span>
###xml 1199 1204 <span type="species:ncbi:10090">mouse</span>
The tail-bleeding assay has been used extensively in mice to assess the impact of deficiencies and over expression of platelet and coagulation proteins in mice. Sweeny et al [28] screened 25 strains of mice and found only the RIIS/J mice to have increased bleeding time due to reduced von Willebrand antigen. Broze et al [29] evaluated mice with gene deletions of the coagulation pathway and found that while bleeding time was not increased, rebleeding persisted despite electrocautery of the tail in FVIII and FIX deficient mice. This observation raised the possibility that rebleeding time may be a sensitive reporter of genetic influences on thrombus formation and stability. Mice that are deficient in factors required for normal platelet function, platelet glycoprotein Ib [30], and protease-activated receptor-4, [31] have increased tail bleeding time. The leptin deficiency with reduced platelet aggregation clearly shows a marked increase in bleeding time and the increased bleeding time in Plg-/- and uPA-/- mice suggests that Plg and uPA may exert an influence on platelet response to promote normal thrombus formation. Overall, the marked increase in rebleeding times observed in certain mouse strains suggests genetic factors other than coagulation may play a role in the stability of a thrombus.
###end p 62
###begin p 63
###xml 473 479 473 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 480 482 480 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 32 36 <span type="species:ncbi:10090">mice</span>
###xml 122 126 <span type="species:ncbi:10090">mice</span>
###xml 149 153 <span type="species:ncbi:10090">mice</span>
###xml 234 238 <span type="species:ncbi:10090">mice</span>
###xml 292 296 <span type="species:ncbi:10090">mice</span>
###xml 459 463 <span type="species:ncbi:10090">mice</span>
###xml 553 557 <span type="species:ncbi:10090">mice</span>
###xml 573 577 <span type="species:ncbi:10090">mice</span>
###xml 787 791 <span type="species:ncbi:10090">mice</span>
###xml 833 837 <span type="species:ncbi:10090">mice</span>
In the tail bleeding assay, A/J mice did not have changes in bleeding time, but rebleeding time was higher compared to B6 mice. In our study, Plg-/- mice had increased bleeding time, PAI-1-/- had decreased rebleeding time, and uPA-/- mice had an increased bleeding time similar to the Plg-/- mice (J. Hoover-Plow, A. Shchurin, and E. Hart, unpublished results). Increased bleeding or rebleeding times have not been reported in any of the Plg network targeted mice. Matsuno et al [32] reported no difference in bleeding time for tPA-/-, uPA-/-, PAI-1-/- mice compared to WT mice, and the assay was similar, but the tail clip segment was considerably shorter and bleeding times reduced compared to the times reported in our study. Bleeding time has not been previously reported for Plg-/- mice. We have found similar values for Plg-/- mice in a 50%B6:50%129 background (J. Hoover-Plow, A. Shchurin, and E. Hart, unpublished results). The results of this study suggest that not only is bleeding time genetically determined by background, but also that tail rebleeding time is genetically determined.
###end p 63
###begin p 64
###xml 158 160 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 161 163 161 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 457 459 457 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 468 471 468 471 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ob </sup>
###xml 472 474 472 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 475 477 475 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 52 56 <span type="species:ncbi:10090">mice</span>
###xml 165 169 <span type="species:ncbi:10090">mice</span>
###xml 252 256 <span type="species:ncbi:10090">mice</span>
###xml 300 304 <span type="species:ncbi:10090">mice</span>
###xml 379 383 <span type="species:ncbi:10090">mice</span>
###xml 479 483 <span type="species:ncbi:10090">mice</span>
###xml 715 719 <span type="species:ncbi:10090">mice</span>
###xml 894 898 <span type="species:ncbi:10090">mice</span>
While blood pressure could conceivably be higher in mice with elevated tail bleeding time, several studies suggest that this is not the case. Studies of A/J [33-36] mice have reported either decreased blood pressure or no difference compared to the B6 mice. Blood pressure was measured in the Plg-/- mice (D. Hellard, J. Hoover-Plow, and E. Plow, unpublished results), and these mice have reduced blood pressure when compared to WT littermates, and uPA-/- [37] and Lepob [38,39] mice also have reduced blood pressure, but there is no correspondence between blood pressure and tail bleeding or rebleeding times. Morphometric analysis of the tail indicated a difference in the collagen content of the tail in the A/J mice. Differences in the structure and/or metabolism of collagen or extracellular matrix proteins may contribute to the increased rebleeding and reduced occlusion time in the A/J mice and warrant further investigation.
###end p 64
###begin p 65
###xml 35 36 31 32 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 501 502 493 494 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 596 598 588 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 1281 1282 1269 1270 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 199 203 <span type="species:ncbi:10090">mice</span>
###xml 366 370 <span type="species:ncbi:10090">mice</span>
###xml 396 400 <span type="species:ncbi:10090">mice</span>
###xml 410 414 <span type="species:ncbi:10090">mice</span>
###xml 541 546 <span type="species:ncbi:10090">mouse</span>
###xml 590 594 <span type="species:ncbi:10090">mice</span>
###xml 640 644 <span type="species:ncbi:10090">mice</span>
###xml 660 664 <span type="species:ncbi:10090">mice</span>
###xml 887 891 <span type="species:ncbi:10090">mice</span>
###xml 1065 1069 <span type="species:ncbi:10090">mice</span>
###xml 1314 1318 <span type="species:ncbi:10090">mice</span>
The genes for Plg, PAI-1, and alpha2-antiplasmin reside on the three chromosomes identified for QTL for rebleeding time and may or may not be coincidental to the observed phenotypes found in the A/J mice and CSS. It is not likely that merely the concentration of these components explains the increased rebleeding time and reduced arterial occlusion time in the A/J mice. When compared to the B6 mice, the A/J mice and the three strains with elevated rebleeding time had variable Plg, PAI-1, and alpha2-antiplasmin. Two allelic forms of the mouse Plg gene have been reported for B6 and A/J mice [40]. Plg concentration was increased in A/J mice compared to B6 mice. Although we did not detect differences in Plg structure, this would not exclude possible functional differences. A congenic strain (specific for a homosomic region from A/J and the remaining Chr and background is from B6 mice) of A/J chromosome 17 that includes the Plg gene was tested in the bleeding assay. Values for bleeding and rebleeding in this congenic strain were similar to values from B6 mice, indicating that the QTL is not Plg. There are genes for other proteases and matrix proteins that reside on chromosome 17 in addition to unknown genes. DNA base pair sequence data for the PAI-1 gene or the alpha2-antiplasmin gene in B6 and A/J mice have reported no differences [51], but regulatory genes upstream of the coding region may be important. Our results suggest that novel or unknown genes may interact with the Plg system components to modify their function.
###end p 65
###begin p 66
###xml 135 137 135 137 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 75 79 <span type="species:ncbi:10090">mice</span>
###xml 294 298 <span type="species:ncbi:10090">mice</span>
In summary, this study reports marked differences in two inbred strains of mice, B6 and A/J, in arterial thrombosis formation in a FeCl3 vascular injury model, rebleeding time in a tail bleeding assay, plasminogen function, and tissue and vessel collagen deposition. Three chromosomes from A/J mice were identified that had QTL for rebleeding time. The genes may interact with components in the Plg network and modulate arterial occlusion time.
###end p 66
###begin title 67
Conclusion
###end title 67
###begin p 68
###xml 66 70 <span type="species:ncbi:10090">mice</span>
The marked independent differences demonstrated in the B6 and A/J mice can be exploited to identify genetic determinants of thrombosis and haemostasis. Our results of the CSS screening suggest that novel or unknown genes can be used to identify the genes responsible for the traits related to arterial thrombosis, tail bleeding/rebleeding and vessel extracellular matrix. Identification of differences in the parent strains, such as those described in this study, and screening of the CSS is a first-step in the discovery of new genetic determinants of thrombotic risk.
###end p 68
###begin title 69
Abbreviations
###end title 69
###begin p 70
B6 = C57BL/6J
###end p 70
###begin p 71
CSS = chromosome substitution strains
###end p 71
###begin p 72
###xml 16 19 16 19 <sup xmlns:xlink="http://www.w3.org/1999/xlink">A/J</sup>
CSS-# = B6-Chr #A/J
###end p 72
###begin p 73
CSS-#F1 = (B6 x CSS-#)F1
###end p 73
###begin p 74
WT = wild-type
###end p 74
###begin p 75
-/- = deficient
###end p 75
###begin p 76
Plg = plasminogen
###end p 76
###begin p 77
PAI-1 = plasminogen activator inhibitor-1
###end p 77
###begin p 78
tPA = tissue plasminogen activator
###end p 78
###begin p 79
uPA = urokinase plasminogen activator
###end p 79
###begin p 80
SEM = standard error of the mean
###end p 80
###begin p 81
QTL = quantitative trait locus
###end p 81
###begin title 82
Competing interests
###end title 82
###begin p 83
The author(s) declare that they have no competing interests.
###end p 83
###begin title 84
Authors' contributions
###end title 84
###begin p 85
###xml 341 346 <span type="species:ncbi:10090">mouse</span>
JHP conceived and designed the study, coordinated the experiments and drafted the manuscript. AS developed and performed the tail bleeding assay and participated in drafting the manuscript. EH carried out the vascular injury model and analyses and the tail bleeding assay, participated in the tail collagen analyses, and coordination of the mouse breeding. JS participated in the analysis of the vascular injury model results and collagen analyses. JHN and AHE provided the CSS breeding pairs, JHN participated in discussions of the results, and JBS and JHN developed the CSS. All the authors have read and approved the final manuscript.
###end p 85
###begin title 86
Pre-publication history
###end title 86
###begin p 87
The pre-publication history for this paper can be accessed here:
###end p 87
###begin p 88

###end p 88
###begin title 89
Acknowledgements
###end title 89
###begin p 90
The authors thank Dr. A. Vasanji, Shiyang Wang, and Jenna Saraniti for assistance with image analyses, David Hellard for performing the blood pressure measurements, Dr. Y.Shchurina for the plasminogen analyses, Drs. Lindsey Burrage and Jonathan Smith for helpful discussions, and Robin Lewis for assistance with manuscript preparation. This study was supported by grants from NIH, HL17964, HL65204, HL078701 (JHP), T32 HL07914 (AS), and RR12305 (JHN).
###end p 90
###begin article-title 91
Genetic susceptibility to death from coronary heart disease in a study of twins
###end article-title 91
###begin article-title 92
Vascular-bed-specific hemostasis and hypercoagulable states
###end article-title 92
###begin article-title 93
Laboratory markers in the diagnosis of venous thromboembolism
###end article-title 93
###begin article-title 94
The study of gene-environment interactions that influence thrombosis and fibrinolysis. Genetic variation at the loci for factor VII and plasminogen activator inhibitor-1
###end article-title 94
###begin article-title 95
Thrombin and fibrinolysis
###end article-title 95
###begin article-title 96
Genetic determinants of arterial thrombosis
###end article-title 96
###begin article-title 97
Atherosclerosis
###end article-title 97
###begin article-title 98
###xml 103 107 <span type="species:ncbi:10090">mice</span>
Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice
###end article-title 98
###begin article-title 99
###xml 71 75 <span type="species:ncbi:10090">mice</span>
Variation in susceptibility to atherosclerosis among inbred strains of mice
###end article-title 99
###begin article-title 100
###xml 58 62 <span type="species:ncbi:10090">mice</span>
Strain-dependent vascular remodeling phenotypes in inbred mice
###end article-title 100
###begin article-title 101
Analysing complex genetic traits with chromosome substitution strains
###end article-title 101
###begin article-title 102
###xml 77 82 <span type="species:ncbi:10090">mouse</span>
Two quantitative trait Loci for prepulse inhibition of startle identified on mouse chromosome 16 using chromosome substitution strains
###end article-title 102
###begin article-title 103
###xml 77 81 <span type="species:ncbi:10090">mice</span>
Genetic dissection of complex traits with chromosome substitution strains of mice
###end article-title 103
###begin article-title 104
###xml 40 44 <span type="species:ncbi:10090">mice</span>
Homocysteine levels in A/J and C57BL/6J mice: genetic, diet, gender and parental effects
###end article-title 104
###begin article-title 105
###xml 49 53 <span type="species:ncbi:10090">mice</span>
Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterization
###end article-title 105
###begin article-title 106
###xml 49 53 <span type="species:ncbi:10090">mice</span>
Effects of disruption of the plasminogen gene in mice on thrombosis, growth and health
###end article-title 106
###begin article-title 107
Apo(a) promotes throombosis in a vascular injury model by a mechanism independent of plasminogen
###end article-title 107
###begin article-title 108
###xml 125 129 <span type="species:ncbi:10090">mice</span>
Plasminogen activator inhibitor type 1 enhances neointima formation after oxidative vascular injury in atherosclerosis-prone mice
###end article-title 108
###begin article-title 109
###xml 76 80 <span type="species:ncbi:10090">mice</span>
Regulation of arterial thrombolysis by plasminogen activator inhibitor-1 in mice
###end article-title 109
###begin article-title 110
###xml 85 90 <span type="species:ncbi:9606">human</span>
Standardization of methods for measuring plasminogen activator inhibitor activity in human plasma
###end article-title 110
###begin article-title 111
###xml 72 77 <span type="species:ncbi:9606">human</span>
Lipoproteins inhibit the secretion of tissue plasminogen activator from human endothelial cells
###end article-title 111
###begin article-title 112
###xml 21 27 <span type="species:ncbi:9986">rabbit</span>
###xml 29 32 <span type="species:ncbi:10116">rat</span>
###xml 37 42 <span type="species:ncbi:10090">mouse</span>
Plasminogen assay in rabbit, rat and mouse plasma using the chromogenic substrate s-2251
###end article-title 112
###begin article-title 113
###xml 63 69 <span type="species:ncbi:10090">murine</span>
Plasminogen-dependent and -independent proteolytic activity of murine endothelioma cells with targeted inactivtion of fibrinolytic genes
###end article-title 113
###begin article-title 114
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
Murine thrombosis models
###end article-title 114
###begin article-title 115
###xml 54 57 <span type="species:ncbi:10116">rat</span>
Shear stress is differentially regulated among inbred rat strains
###end article-title 115
###begin article-title 116
Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity
###end article-title 116
###begin article-title 117
###xml 112 116 <span type="species:ncbi:10090">mice</span>
Inhibitors of fibrinolytic components play different roles in the formation and removal of arterial thrombus in mice
###end article-title 117
###begin article-title 118
###xml 19 24 <span type="species:ncbi:10090">mouse</span>
The RIIIS/J inbred mouse strain as a model for von Willebrand disease
###end article-title 118
###begin article-title 119
###xml 68 72 <span type="species:ncbi:10090">mice</span>
A tail vein bleeding time model and delayed bleeding in hemophiliac mice
###end article-title 119
###begin article-title 120
###xml 20 25 <span type="species:ncbi:10090">mouse</span>
Genetic deletion of mouse platelet glycoprotein Ibb produced a bernard-soulier phenotype with increased a-granule size
###end article-title 120
###begin article-title 121
###xml 97 101 <span type="species:ncbi:10090">mice</span>
Impaired hemostasis and protection against thrombosis in protease-activated receptor 4-deficient mice is due to lack of thrombin signaling in platelets
###end article-title 121
###begin article-title 122
Differential role of components of the fibrinolytic system in the formation and removal of thrombus induced by endothelial injury
###end article-title 122
###begin article-title 123
###xml 74 79 <span type="species:ncbi:10090">mouse</span>
Endothelial dysfunction and blood pressure variability in selected inbred mouse strains
###end article-title 123
###begin article-title 124
###xml 68 73 <span type="species:ncbi:10090">mouse</span>
Naturally occurring variation in cardiovascular traits among inbred mouse strains
###end article-title 124
###begin article-title 125
###xml 62 66 <span type="species:ncbi:10090">mice</span>
Comparison of arterial blood pressure in different strains of mice
###end article-title 125
###begin article-title 126
###xml 44 48 <span type="species:ncbi:10090">mice</span>
Mapping blood pressure loci in (A/J x B6)F2 mice
###end article-title 126
###begin article-title 127
Binding of urokinase to low density lipoprotein-related receptor (LRP) regulates vascular smooth muscle cell contraction
###end article-title 127
###begin article-title 128
###xml 72 76 <span type="species:ncbi:10090">mice</span>
###xml 101 105 <span type="species:ncbi:10090">mice</span>
Contrasting blood pressure effects of obesity in leptin-deficient ob/ob mice and agouti yellow obese mice
###end article-title 128
###begin article-title 129
Altered leptin signaling is sufficient, but not required, for hypotension associated with caloric restriction
###end article-title 129
###begin article-title 130
###xml 40 45 <span type="species:ncbi:10090">mouse</span>
###xml 90 95 <span type="species:ncbi:10090">mouse</span>
Characterization of the cDNA coding for mouse plasminogen and localization of the gene to mouse chromosome 17
###end article-title 130
###begin article-title 131
###xml 84 89 <span type="species:ncbi:10090">mouse</span>
The influence of genetic background on the expression of the obese (Ob) gene in the mouse
###end article-title 131
###begin article-title 132
###xml 74 78 <span type="species:ncbi:10090">mice</span>
Severe hypercholesterolemia, hypertriglyceridemia, and atherosclerosis in mice lacking both leptin and the low density lipoprotein receptor
###end article-title 132
###begin article-title 133
###xml 61 65 <span type="species:ncbi:10090">mice</span>
Leptin promotes vascular remodeling and neointimal growth in mice
###end article-title 133
###begin article-title 134
In vivo plasminogen deficiency reduces fat accumulation
###end article-title 134
###begin article-title 135
###xml 58 62 <span type="species:ncbi:10090">mice</span>
Plasminogen deficiency accelerates vessel wall disease in mice predisposed to atherosclerosis
###end article-title 135
###begin article-title 136
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
Murine model of accelerated transplant arteriosclerosis
###end article-title 136
###begin article-title 137
###xml 41 45 <span type="species:ncbi:10090">mice</span>
Impaired arterial neointima formation in mice with disruption of the plasminogen gene
###end article-title 137
###begin article-title 138
###xml 64 68 <span type="species:ncbi:10090">mice</span>
Plasminogen is a critical determinant of vascular remodeling in mice
###end article-title 138
###begin article-title 139
Molecular genetics of the fibrinolytic and coagulation systems in haemostasis, thrombogenesis, restenosis and atherosclerosis
###end article-title 139
###begin article-title 140
###xml 82 86 <span type="species:ncbi:10090">mice</span>
Remodeling of the vessel wall after copper-induced injury is highly attenuated in mice with a total deficiency of plasminogen activator inhibitor-1
###end article-title 140

